Barrington Research Maintains Outperform on OPKO Health, Raises Price Target to $2.25
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky maintains an Outperform rating on OPKO Health (NASDAQ:OPK) and raises the price target from $1.5 to $2.25.
August 08, 2024 | 4:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research analyst Michael Petusky maintains an Outperform rating on OPKO Health and raises the price target from $1.5 to $2.25.
The raised price target and maintained Outperform rating by Barrington Research are positive signals for OPKO Health, likely leading to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100